Acrivon Therapeutics, Inc. (ACRV)
1.86
+0.03
(+1.64%)
USD |
NASDAQ |
Jan 15, 16:00
1.86
0.00 (0.00%)
After-Hours: 16:18
Acrivon Therapeutics Shareholders Equity (Quarterly): 128.60M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Aclarion, Inc. | 12.50M |
| Vistagen Therapeutics, Inc. | 66.34M |
| Spero Therapeutics, Inc. | 26.49M |
| Humacyte, Inc. | -4.751M |
| PMGC Holdings, Inc. | 8.491M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 145.30M |
| Total Liabilities (Quarterly) | 16.70M |
| Debt to Equity Ratio | 0.0232 |
| Current Ratio | 8.754 |
| Net Debt Paydown Yield | 0.43% |